Ultrasound Imaging of Fibrotic Tissue
Launched by PEKING UNIVERSITY THIRD HOSPITAL · Apr 5, 2023
Trial Information
Current as of July 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how ultrasound imaging can help us understand and treat stiffness in the shoulder and knee joints caused by a condition known as arthrofibrosis. Researchers want to gather detailed ultrasound information about the fibrotic (scar-like) tissues in these joints and use advanced computer methods to learn more about how this stiffness develops. Ultimately, the goal is to create better ways to diagnose and treat joint stiffness, helping patients regain movement and improve their overall quality of life.
To participate in this study, you need to be at least 18 years old and have stiffness in one shoulder or knee joint, with the other joint working normally. It's important that your stiffness has lasted for more than three months and that you can understand the study details and agree to participate. However, if you have certain issues like open wounds, joint infections, or other conditions that could affect your ability to undergo an ultrasound, you may not be eligible. If you join the trial, you can expect to contribute to important research that aims to enhance treatment options for joint stiffness, helping you and others get back to daily activities more effectively.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Unilateral shoulder or knee joint stiffness and normal on the opposite side
- • 2. The course of the disease is longer than 3 months
- • 3. Good cognitive function, able to understand the content of this experiment, willing to cooperate with follow-up
- • 4. Over 18 years old, voluntarily participate in this study, and sign the informed consent
- Exclusion Criteria:
- • 1. Wound non-healing, joint dislocation or unstable fracture fixation, pseudarthrosis, joint purulent infection and other contraindications for joint range of motion examination
- • 2. There are skin lesions, wounds or allergies to the coupling agent on the joint surface and other conditions that cannot be used for ultrasound examination
About Peking University Third Hospital
Peking University Third Hospital is a leading medical institution in China, renowned for its commitment to advanced healthcare, innovative research, and comprehensive clinical services. As a prominent sponsor of clinical trials, the hospital emphasizes the integration of cutting-edge scientific research with patient-centered care to enhance therapeutic outcomes. With a multidisciplinary approach, the institution fosters collaboration among top-tier medical professionals and researchers, striving to contribute to the global medical community through rigorous clinical studies that address pressing health challenges. Its dedication to ethical standards and regulatory compliance ensures the safety and efficacy of new treatments, ultimately aiming to improve patient care and outcomes on both a national and international scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Beijing, , China
Beijing, , China
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported